Clin Pharmacokinet 56(11):13911401 Vazquez SR (2018) Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus
These metabolic benefits occur through enhanced insulin sensitivity, reduced hepatic glucose production, and decreased caloric intake
Understanding the Relationship Between NAC and Glutathione To understand if one is better than the other, we first need to look at how they work together
On this page, we share: - Insights into current research surrounding NADH & cellular energy - Background from decades of scientific work - Practical knowledge for medical professionals, longevity, anti-aging, and nutrition experts, as well as health enthusiasts - Updates from our international community We look forward to having you join us on this journey
AMCP Nexus in focus: Exploring Primes GLP-1 research in depth Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s Prior to the release of Prime Therapeutics (Prime) latest cost-of-care data from its ongoing real-world research on glucagon-like peptide-1 (GLP-1) agonist drugs, Prime researchers presented findings from the Year-2 adherence and persistence study as a research poster and an education session at Academy of Managed Care Pharmacy (AMCP) Nexus 2024 in Las Vegas, Nevada
